|
|
DSpace at King Saud University >
King Saud University >
COLLEGES >
Health Colleges >
College of Pharmacy >
College of Pharmacy >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/5213
|
| Title: | Taurine attenuates hypertension and renal dysfunction induced by cyclosporine a in rats |
| Authors: | Hagar, H.H El Etter, E Arafa, M. |
| Keywords: | Taurine Cyclosporine Rats ROS CsA group |
| Issue Date: | Mar-2006 |
| Publisher: | Blackwell Publishing Asia |
| Citation: | Clinical and Experimental Pharmacology and Physiology :33(3); 189-196. |
| Abstract: | Cyclosporine A (CsA) is the first-line immunosuppressant used for the management
of solid organ transplantation and autoimmune diseases. Nephrotoxicity is the
major limitation of CsA use. Recent evidence suggests that reactive oxygen
species (ROS) play an important role in mediating CsA-induced hypertension and
nephrotoxicity. Taurine, the major intracellular free beta-amino acid, is known
to be an endogenous anti-oxidant and membrane-stabilizing agent. The present
study was designed to investigate the effects of taurine on CsA-induced
oxidative stress, hypertension and renal dysfunction. 2. Animals were assigned
into four groups of seven rats each as follows: (i) control group, receiving
vehicle (olive oil; 1 mL/kg, s.c.); (ii) CsA group, given CsA (25 mg/kg per day,s.c.) for 21 days; (iii) taurine group, supplemented with taurine (1% in the
drinking water); and (iv) taurine + CsA group, treated with taurine 3 days
before and concurrently during CsA injections for 21 days. 3. Cyclosporine A
administration elevated blood pressure, reduced serum nitric oxide (NO) levels
and deteriorated renal function, as assessed by increased serum creatinine
levels and proteinuria and reduced urine flow rate and creatinine clearance
compared with vehicle-treated rats. Cyclosporine A induced oxidative stress, as
indicated by increased renal tissue concentrations of thiobarbituric
acid-reactive substances and reduced concentrations of renal glutathione,
glutathione peroxidase and superoxide dismutase. Conversely, no change was noted
in renal catalase activity. Moreover, the kidneys of CsA-treated rats showed
interstitial inflammation and renal tubular atrophy. 4. Taurine markedly reduced
elevated blood pressure, attenuated renal dysfunction and the reduction in serum
NO levels and counteracted the deleterious effects of CsA on oxidative stress
markers. Furthermore, taurine ameliorated CsA-induced morphological changes. 5.
These data clearly indicate the protective potential of taurine against
CsA-induced hypertension and nephrotoxicity and suggest a significant
contribution of its anti-oxidant property to this beneficial effect. |
| Description: | Department of Pharmacology, College of Medicine and King Khalid University
Hospital, King Saud University, Riyadh, Saudi Arabia |
| URI: | http://hdl.handle.net/123456789/5213 |
| Appears in Collections: | College of Pharmacy
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|